Spina, Michele <br/><br/>
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 2007 
 - e7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comment; Letter 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2006.09.0407  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--therapeutic use<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Lymphoma, AIDS-Related--diagnosis<br/>Lymphoma, Non-Hodgkin--diagnosis<br/>Male<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Rituximab<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--therapeutic use